For the Quarter Ending December 2025
North America
• In USA, the Melatonin Price Index fell by 1.73% quarter-over-quarter, reflecting subdued demand and inventory levels.
• The average Melatonin price for the quarter was approximately USD 89275.00/MT, amid balanced procurement patterns.
• Melatonin Spot Price remained range-bound amid normal operating rates, limiting sudden volatility in wholesale trading.
• Melatonin Price Forecast signals mild sideways movement near term, supported by steady supply and caution.
• Melatonin Production Cost Trend showed negligible upstream pressure as L-tryptophan feedstock moves didn't affect costs.
• Melatonin Demand Outlook remains subdued, with nutraceutical and pharmaceutical buyers drawing down inventories cautiously currently.
• Retail promotions and safety-related headlines intermittently pressured the Melatonin Price Index despite efficient logistics continuity.
• Export demand softened, inventories remained elevated, and US producers ran reliably, supporting Melatonin export availability.
Why did the price of Melatonin change in December 2025 in North America?
• Steady domestic production and uninterrupted L-tryptophan inflows limited upward pressure despite modest feedstock cost increases.
• Seasonal retail promotions boosted consumption while safety-related headlines reduced forward purchasing and tempered procurement intensity.
• Efficient port and inland logistics, ample inventories, and stronger US dollar offset modest freight impacts.
APAC
• In China, Melatonin Price Index fell by 2.44% quarter-over-quarter, driven by oversupply and weak exports.
• The average Melatonin price for the quarter was USD 61748.00/MT, based on EXW and FOB.
• Melatonin Spot Price softened as exporters offered cautious volumes while domestic buyers ran down inventories.
• Melatonin Price Forecast expects near-term softening as muted procurement offsets post-holiday restocking impulses from formulators.
• Melatonin Production Cost Trend was neutral as indole and tryptophan prices remained broadly stable overall.
• Melatonin Demand Outlook stayed subdued with nutraceutical brands delaying purchases while e-commerce promotions provided support.
• Melatonin Price Index movements reflected steady logistics, port operations, failing to offset weak export orders.
• Producers prioritized contract fulfillment, limiting aggressive spot discounts while inventories remained elevated across bonded warehouses.
Why did the price of Melatonin change in December 2025 in APAC?
• Weak international demand and inventory builds reduced exporter leverage, pressuring Melatonin Price Index in December.
• Easing freight and stable feedstock trimmed landed costs, removing upstream cost support for Melatonin prices.
• Buyers delayed replenishment ahead of year-end, sustaining subdued spot demand and muted Price Index momentum.
Europe
• In Europe, the Melatonin Price Index declined modestly quarter-over-quarter, reflecting oversupply from imports and muted export enquiries.
• The average Melatonin price for the quarter was approximately USD 61,500.00/MT, based on CFR assessments across major European markets.
• Melatonin Spot Prices softened as distributors reduced spot purchases, relying on existing bonded warehouse inventories.
• Melatonin Price Forecast indicated continued near-term softening, with subdued procurement by nutraceutical brands offsetting occasional e-commerce or seasonal promotions.
• Melatonin Production Cost Trend remained neutral, with indole and tryptophan feedstock prices broadly stable.
• Melatonin Demand Outlook stayed cautious, as formulators deferred incremental purchases, and winter holiday orders were largely pre-covered.
• Price Index movements were restrained, with logistics and port operations steady but insufficient to counter weak buying momentum.
• Producers focused on fulfilling contract volumes, limiting aggressive spot discounts while inventories remained adequate.
Why did the price of Melatonin change in December 2025 in Europe?
• Oversupply and weak international demand reduced importer leverage, pressuring the Melatonin Price Index.
• Stable feedstock and freight costs lowered upstream cost support, allowing suppliers to maintain disciplined offers.
• Deferred purchases by nutraceutical brands and controlled distributor inventories sustained subdued spot demand and muted price movement.
For the Quarter Ending September 2025
North America
• In USA, the Melatonin Price Index rose by 0.27% quarter-over-quarter, reflecting steady operational demand patterns.
• The average Melatonin price for the quarter was approximately USD 90843.33/MT reported by export assessments.
• Melatonin Spot Price remained muted while regional Price Index showed limited volatility amid balanced inventory
• Melatonin Price Forecast suggests firmness into autumn driven by structured procurement and steady export flows
• Melatonin Production Cost Trend remained stable with no feedstock spikes, supporting exporters' Price Index discipline
• Melatonin Demand Outlook indicates seasonal pickup in year end with downstream replenishment supporting Price Index
• Inventory levels remained adequate, constraining upside while export demand improvement supported a firmer Price Index
• Major producers operated uninterrupted, logistics smooth, enabling steady shipments and limiting Melatonin Price Index volatility
Why did the price of Melatonin change in September 2025 in North America?
• Balanced inventories and steady production limited restocking urgency, reducing upward pressure on the Price Index
• Stable feedstock availability and smooth logistics prevented cost inflation, constraining Melatonin Spot Price, limiting volatility
• Cautious buying amid political uncertainty slowed orders, tempering demand and muting Melatonin Price Index momentum
APAC
• In China, the Melatonin Price Index fell by 10.63% quarter-over-quarter, reflecting weak demand and high inventories.
• The average Melatonin price for the quarter was approximately USD 63677.67/MT, supported by steady production and subdued replenishment activity.
• Melatonin Spot Price remained volatile early quarter but stabilized as exporters adjusted offers to clear elevated global inventories.
• Melatonin Price Forecast indicates modest recovery potential as autumn procurement resumes and buyers cautiously replenish strategic inventories.
• Melatonin Production Cost Trend was neutral with stable feedstock availability and unchanged energy costs supporting consistent output.
• Melatonin Demand Outlook remains subdued short term despite pockets of retail strength, supporting measured, needs-based purchasing.
• Melatonin Price Index volatility reflected exporters offering marginal discounts during destocking, then modest firmness as restocking began.
• Logistics remained efficient, inventories high, and major producers operated reliably, limiting short-term upside and sustaining price pressure.
Why did the price of Melatonin change in September 2025 in APAC?
• Oversupply driven by steady Chinese output and high inventories pressured September pricing despite orderly logistics.
• Weak end-user demand and cautious buyer replenishment cycles reduced urgency, translating into downward price momentum.
• Stable feedstock costs limited cost-push inflation, preventing producer margin-driven hikes during the September selling period.
Europe
• In major EU import hubs (Germany/Netherlands), the Melatonin Price Index fell by ~11.0% quarter-over-quarter, reflecting weak demand and elevated inventories.
• The average Melatonin price for the quarter was approximately USD 63,700/MT for CFR Rotterdam imports (conservative regional estimate).
• Melatonin Spot Price softened as exporters offered marginal discounts to clear stocks; spot volatility eased once restocking signals remained muted.
• Melatonin Price Forecast indicates limited near-term upside, with modest recovery potential if autumn retail and supplement restocking strengthens.
• Melatonin Production Cost Trend stayed neutral; precursor/feedstock availability and energy costs were broadly stable, containing cost pressures.
• Melatonin Demand Outlook remains subdued short term, with formulators and distributors maintaining needs-based purchasing despite isolated retail pockets.
• High European warehouse stocks and steady import arrivals constrained upward price movement, even as exporters adjusted offers to stimulate orders.
• Efficient Rotterdam/Hamburg logistics and regular shipments from origins limited delivery risk and thus capped volatility despite lower prices.
Why did the price of Melatonin change in September 2025 in Europe?
• Oversupply and high on-hand inventories reduced buying urgency, pressuring September prices.
• Weak end-user demand and cautious replenishment by distributors led to softer spot market activity.
• Stable production costs meant declines were demand-driven rather than cost-related.
For the Quarter Ending June 2025
North America
• Melatonin Spot Price in North America rose firmly through Q2 with the Price Index closing at USD 92,500/MT FOB New York by late June 2025. This uptrend reflected strong domestic and export demand from wellness, pharmaceutical and nutraceutical segments.
• Why did the price change in July 2025?
Melatonin prices in July 2025 moved slightly higher as downstream players rushed to restock amid tightening inventory levels and ongoing consumer focus on sleep health. This renewed buying activity coincided with persistent supply discipline which encouraged a modest price lift.
• The Melatonin Price Forecast for Q3 2025 suggests a cautiously bullish trend, supported by expected seasonal demand for wellness formulations and increased marketing campaigns around stress and sleep support supplements.
• The Melatonin Production Cost Trend in Q2 remained stable as U.S. facilities operated without disruption. Raw material availability and manufacturing continuity enabled reliable supply output throughout the quarter.
• Demand accelerated during May and June as downstream buyers absorbed earlier inventories; this marked a shift from cautious purchasing in April to active procurement by early June, underpinning upward price movements.
• In April, the Melatonin Spot Price reflected a stable operating condition and soft but consistent offtake from domestic buyers. By June, active restocking led to a notable gain across the quarter.
• The Melatonin Demand Outlook remained robust across the wellness and pharmaceutical verticals. Brands and distributors responded to rising consumer awareness with advanced procurement and product formulation.
• Exporters benefited from highly efficient U.S. logistics and no major shipping delays. Strong export fulfilment capabilities bolstered international confidence in American-origin Melatonin.
• Inventory drawdown accelerated in June as downstream formulators moved to secure Q3 supply in advance. This proactive strategy reflected heightened caution over potential future price surges.
• Despite the bullish sentiment, no production bottlenecks or material sourcing challenges were reported in Q2, ensuring a well-balanced supply-demand dynamic.
Asia Pacific
• The Melatonin Spot Price in Shanghai declined modestly across Q2, with the Price Index settling at USD 66,150/MT FOB Shanghai by late June. Seasonal consumption slowdown and high inventory levels pressured prices downward.
• Why did the price change in July 2025?
Melatonin prices in China remained mostly unchanged in July 2025 as exporters held offers steady amidst persistent oversupply and passive demand. Sellers aimed to stabilize the market without deepening discounts, especially as input and logistics costs stayed consistent.
• The Melatonin Price Forecast for Q3 2025 remains cautiously bearish unless export momentum improves. Without significant stimulus or tender activity from overseas buyers, prices may remain rangebound.
• The Melatonin Production Cost Trend held steady during Q2 with uninterrupted manufacturing operations across China. Sufficient feedstock access and smooth processing cycles kept costs predictable.
• Limited price movement during April–June reflected subdued export interest and soft seasonal demand, especially as longer daylight hours reduced consumer reliance on supplemental melatonin.
• The small price dips seen in May and June were inventory-led, as manufacturers sought to offload excess stock from previous cycles to maintain competitiveness in the global market.
• The Melatonin Demand Outlook was subdued, particularly from overseas markets. While wellness and pharma sectors sustained baseline consumption, no large-scale procurement revived market strength.
• Export logistics remained fluid throughout the quarter. Port operations in Shanghai and other key terminals ensured consistent global dispatches, helping prevent price volatility.
• Domestic buyers practiced controlled procurement, avoiding speculative purchases. This sentiment, rooted in sufficient running stock and muted consumer pull, shaped a flat market environment.
• The absence of any significant procurement from Europe or North America in May–June further dampened overall market confidence, keeping pricing trends neutral to soft.
Europe
• The Melatonin Spot Price in Europe showed stability in Q2 2025, with the Price Index hovering around USD 79,500/MT CFR Hamburg, underpinned by steady demand from the health supplement, pharma, and OTC sleep aid markets.
• Why did the price change in July 2025?
In July 2025, Melatonin prices in Europe edged slightly higher due to anticipatory restocking by distributors ahead of expected Q3 wellness product launches. Incremental improvement in consumer sentiment in Northern and Western Europe supported this uptick.
• The Melatonin Price Forecast for Q3 remains mildly positive, backed by seasonal demand for OTC sleep support and wellness-focused products as part of post-summer formulation cycles.
• The Melatonin Production Cost Trend remained stable in Q2 for imported material from China and the U.S., with no significant logistics surcharges or customs bottlenecks affecting CIF values.
• European buyers adopted a lean inventory strategy in April–May, avoiding excess stockholding amid subdued early-summer demand. However, June saw a shift toward pre-emptive purchasing to avoid potential Q3 spot escalations.
• The Melatonin Demand Outlook in Europe remained balanced. While food and nutraceutical segments showed consistent interest, industrial and veterinary sectors displayed a modest pullback.
• Port logistics in key EU hubs like Hamburg, Antwerp, and Rotterdam operated smoothly throughout the quarter, enabling timely inbound shipments and steady supply chain continuity.
• The April–May period witnessed relatively flat pricing as buyers focused on prior inventory utilization. New orders began to emerge only in late June, tightening the supply pipeline slightly.
• European wellness brands adjusted their sourcing rhythm to match summer consumer preferences. Melatonin’s appeal in natural sleep aids and mood-balancing products saw a marginal increase in market pull by the end of Q2.
• No major macroeconomic disruptions, freight rate hikes, or policy changes occurred that could significantly affect production or importation costs, keeping the region’s Melatonin market structurally sound.
For the Quarter Ending March 2025
North America
In the first quarter of 2025, the Melatonin market in North America recorded a quarterly price rise of around 1.55% from previous quarter. This increase was supported by active procurement from melatonin supplement manufacturers and distributors. The seasonal transition from winter to spring played a part in keeping demand firm as consumers remained focused on sleep support and general wellness. The pharmaceutical and nutraceutical sectors showed steady offtake, especially as buyers moved to maintain well-planned inventories ahead of warmer months.
Melatonin suppliers in the region also benefited from smooth logistics and favourable supply conditions. Some influence came from ongoing tariff structures that encouraged local purchasing activity and kept buying interest stable for most of the quarter. Melatonin distributors adjusted their procurement cycles smartly to secure stock while avoiding overbuild, which kept supply-demand balanced.
Overall, the North American Melatonin market displayed healthy activity in first quarter of 2025 which was backed by solid downstream demand, good inventory management and supportive seasonal factors. The market sentiment stayed positive with suppliers reporting regular inquiries and moderate price adjustments.
Asia Pacific
In Asia Pacific, the Melatonin market experienced a modest average price increase of 0.10% during the first quarter of 2025. This trend was largely shaped by steady procurement activities from melatonin supplement and nutraceutical producers in the region. The Lunar New Year holidays in February resulted in temporarily slowed operations. This market temporary production slowdown was balanced by post-holiday restocking and helped in supporting the prices in upward direction.
Seasonal transition from winter to spring also contributed to sustained demand from downstream sectors such as pharmaceuticals and personal care. Melatonin suppliers in key exporting countries maintained reliable inventory positions and helped to ensure smooth distribution within the region. Although some downstream buyers showed cautious purchasing early in the quarter, but the strategic procurement activity picked up gradually as the quarter concluded.
Melatonin distributors responded to market signals and managed inventories effectively to match demand trends. Overall, the market remained balanced without sharp price fluctuations. The slight increase reflected healthy downstream consumption, supportive procurement strategies, and a steady pace of logistical operations across the Asia Pacific Melatonin market during Q1 2025.
Europe
The European Melatonin market in the first quarter of 2025 maintained a steady and controlled pricing pattern and broadly reflected the global market movements. Although pricing levels displayed minor variations across sources, the overall market sentiment held cautiously firm. Price levels demonstrated general stability with a modest upward inclination. This was supported by consistent demand from the pharmaceutical and nutraceutical sectors where melatonin supplements continued to gain consumer interest for sleep health and general wellness.
Melatonin suppliers in Europe reported regular inquiries and maintained strategic procurement schedules to prevent supply tightness. Distributors displayed careful inventory planning which helped in keeping market activity well balanced. Seasonal transition from colder months to early spring influenced purchasing patterns with steady buying observed throughout. The mild rise in demand was mainly driven by preparation for upcoming production cycles and positive downstream sentiment. The overall European Melatonin market in first quarter of 2025 remained steady. The moderate activity from both buyers and suppliers was reflected in a balanced supply-demand fundamentals and smooth distribution conditions.
